Volkan Oezdemir says he knowingly took EPO and tests positive, opening the door to UFC anti-doping consequences

Volkan Oezdemir, a former UFC light heavyweight title challenger, has revealed that he tested positive for EPO, a banned performance-enhancing drug, and acknowledged that he knowingly took it. The disclosure lands him in the center of the UFC’s anti-doping enforcement process, where admissions involving prohibited substances typically carry significant competitive and reputational consequences.

EPO is widely recognized in anti-doping frameworks as a substance that can artificially increase red blood cell production, improving oxygen delivery and endurance. In combat sports, that type of advantage is at odds with the policies meant to protect competitive fairness, which is why EPO has long been treated as a high-priority prohibited substance.

Oezdemir’s disclosure, reported through Yahoo Sports, positions this as more than a routine “positive test” storyline. By describing his conduct as knowing, he is effectively inviting the formal disciplinary process that follows whenever an athlete is found to have violated anti-doping rules, including review of the test result and the circumstances surrounding the violation.

From a UFC light heavyweight perspective, the case matters because the division is built around matchups that hinge on fighter availability and preparation. Even without tying the outcome to any specific timetable or penalty length, the uncertainty surrounding an active or future competitor can affect how promotions plan continuity, matchmaking, and pathways for contenders.

Oezdemir has previously occupied a prominent role in the light heavyweight title picture, and a case like this inevitably re-centers attention on how the UFC and its anti-doping partners handle substances that can impact conditioning and recovery. Fans also tend to look for answers about the broader culture of compliance, including how fighters educate themselves and monitor what goes into training cycles.

What to watch next is the procedural phase: whether there is additional official confirmation tied to the test and the governing anti-doping authority, and how quickly the case moves through whatever hearings or appeals steps apply. Until that happens, the most concrete item remains Oezdemir’s public admission that he knowingly used EPO and that he has been caught, as reported.

For Oezdemir personally, the immediate impact is likely to be felt in career planning and public perception, not just in his next stated fight intentions. For the sport, the story is another reminder that even athletes with top-level resumes can face abrupt career disruption when banned substances intersect with enforcement mechanisms.